luxnabiotech / Luxna Biotech Co.,

Robots.txt Information

Robot	Path	Permission
GoogleBot	/	✔
BingBot	/	✔
BaiduSpider	/	✔
YandexBot	/	✔
User-agent: * Disallow: /wp/wp-admin/ Allow: /wp/wp-admin/admin-ajax.php

Meta Tags

Title	Luxna Biotech Co.,
Description	Luxna Biotech Co., Ltd. EN JP About Oligonucleotide Therapeutics Technology Business Structure News Open Positions Access Contact MENU About Oligonucleoti
Keywords	N/A

Server Information

WebSite	luxnabiotech.co.jp
Host IP	133.130.64.112
Location	Japan

さらに探索する

Site

maeda-seikei-naika.com

luxnabiotech.co.jp 評価

US$2,261,716

最終更新: 2022-10-08 20:46:32

luxnabiotech.co.jp の Semrush グローバルランクは 4,679,767 です。luxnabiotech.co.jp は、推定広告収入に基づいて、US$2,261,716 の推定価値を持っています。 luxnabiotech.co.jp には、毎日約 260,968 人のユニークユーザーがアクセスしています。その Web サーバーは Japan にあり、IP アドレスは 133.130.64.112です。 SiteAdvisor によると、luxnabiotech.co.jp は安全にアクセスできます。

トラフィック & 見積もりの価値

売買価格	US$2,261,716
毎日の広告収入	US$2,088
月間広告収入	US$62,633
年間広告収入	US$751,586
デイリーユニークビジター	17,398
注: トラフィックと収益の値はすべて推定値です。

DNS Records

Host	Type	TTL	Data
luxnabiotech.co.jp.	A	600	IP: 133.130.64.112
luxnabiotech.co.jp.	NS	600	NS Record: dns01.gmoserver.jp.
luxnabiotech.co.jp.	NS	600	NS Record: dns02.gmoserver.jp.
luxnabiotech.co.jp.	MX	600	MX Record: 0 luxnabiotech-co-jp.mail.protection.outlook.com.
luxnabiotech.co.jp.	TXT	600	TXT Record: v=spf1 include:spf.protection.outlook.com -all
luxnabiotech.co.jp.	TXT	600	TXT Record: MS=ms52438170

HtmlToTextCheckTime:2022-10-08 20:46:32

Luxna Biotech Co., Ltd. EN JP About Oligonucleotide Therapeutics Technology Business Structure News Open Positions Access Contact MENU About Oligonucleotide Therapeutics Technology Business Structure News Open Positions Access Contact We contribute to the creation of ground-breaking oligonucleotide therapeutics to bring “light” to patients who are fighting a disease and to those who support them. NEWS 2022/02/24 Notice Notice of exclusive license agreement for artificially modified nucleic acid technology with Takeda Pharmaceutical Company Limited 2021/12/16 Notice Notice of Fundraising 2021/12/10 Notice Achieved milestonesbased on the technology license agreement with Aligos Therapeutics. Business Structure Manage XNA sub-license program to third party Development of oligonucleotide therapeutics in cooperation with Pharma and Biotech Our original drug development program Oligonucleotide CMC consultation More Technology Modified bridged oligonucleotides, which are licensed to us, have

HTTP Headers

HTTP/1.1 301 Moved Permanently
Date: Sun, 30 Jan 2022 09:55:29 GMT
Server: Apache
Location: https://luxnabiotech.co.jp/
Content-Type: text/html; charset=iso-8859-1

luxnabiotech.co.jp Whois Information

Cannot process your search request.
Service currently unavailable due to incoming of a large amount of
requests.
Try again later.

luxnabiotech.co.jp 評価と分析